首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献,搜索用时 781 毫秒
1.
[目的]探讨根据精准肝切除理念行腹腔镜肝切除治疗原发性肝癌的方法与价值.[方法]回顾分析63例原发性肝细胞癌患者,遵循精准肝切除理念行腹腔镜下精准肝切除术.手术主要方式是根据术前影像资料精确定位病变范围,根据病变范围行选择性的入肝血流阻断或行遵循肝脏内部解剖结构的规则性肝切除.[结果]63例患者中,61例完全腹腔镜下完成,2例中转开腹,中转开腹率3.17%.腹腔镜平均手术时间(210±90)min,平均出血量(400±90)ml.术后出现腹水6例,右膈下积液2例,右侧胸腔积液7例,胆瘘1例,经相应处理均顺利康复,术后平均住院时间(9±3)d.[结论]腹腔镜行选择性入肝血流阻断,并行基于肝段、叶的腹腔镜规则性肝切除术治疗肝癌是安全可行的,符合当代精准肝切除的理念,有良好的应用前景.  相似文献   

2.
目的:评价老年结直肠癌腹腔镜根治术的安全可行性及应用价值.方法:回顾性分析广东省人民医院2006年6月至2008年3月同期收治的结直肠癌老年患者腹腔镜手术组(54例)和传统开腹手术组(49例),分析其临床资料.结果:腹腔镜组其中3例中转开腹手术,中转率为5.6%.腹腔镜组的手术失血量明显较开腹组少(83.1mL±25.7mL VS 276.3mL±187.2mL,P<0.001):腹腔镜组的手术时间较开腹组稍长(193.1min±58.2min vs160.1min±54.3min,P<0.05);腹腔镜组的肠道功能恢复时间较开腹组短(2.5d±0.7d VS 4.3d±0.8d,P<0.05),腹腔镜组手术后住院天数较短.手术后并发症且平均收获的淋巴结数两组间无统计学差异.结论:老年结直肠癌腹腔镜根治术是一种安全、有效的手术方式,是治疗老年人结直肠癌的较好选择.细致的围手术期处理和熟练的腹腔镜手术经验是取得良好疗效的关键.  相似文献   

3.
  目的  探讨完全腹腔镜解剖性肝切除治疗左叶肝细胞癌的可行性及其疗效。  方法  自2006年6月至2009年12月间, 总结南昌大学第二附属医院肝胆外科收治21例确诊为左叶肝细胞癌且已行完全腹腔镜解剖性肝切除(laparoscopic anatomic hepateetomy, LAH)患者的围手术期的临床资料, 构成LAH研究组。在同一时间段, 以患者年龄、手术方式、肿瘤大小、肝硬化程度为配对条件, 在开腹解剖性肝切除治疗左叶肝细胞癌的病例库中进行1:1配对抽选, 共21例纳入LAH配对组。  结果  LAH研究组的手术时间为(156.67±32.15)min, 术中失血量为(157.14±40.51)mL, 两者均少于配对组(P=0.036, P < 0.001)。LAH研究组术后患者平均镇痛剂使用时间为(2.19±0.51)d, 平均首次进食时间为(2.24±0.44)d, 平均首次离床活动时间为(2.71±0.78)d, 平均住院时间为(7.86±1.24)d, 均优于配对组(P < 0.05)。两组并发症及死亡率差异没有统计学意义。术后中位随访期为21个月, LAH研究组的1、3年总体生存率分别为86%、62%, 配对组的1、3年总体生存率分别为90%、67%, Log-rank比较两组肝癌患者生存曲线差异无统计学意义。  结论  完全腹腔镜解剖性肝切除术治疗左叶肝细胞癌是安全可行, 具有一定的近期优势, 且术后总体生存率与开腹肝切除术相比无差别。   相似文献   

4.
目的 评估腹腔镜下经肝门板半肝血流阻断方法在左半肝切除中的安全性和可行性.方法 我院2010年9月至2011年4月采用腹腔镜下经肝门板半肝血流阻断方法行左半肝切除5例患者,分析其术中手术情况及术后并发症及肝功能情况.结果 5例患者均顺利完成手术,无中转开腹.术中出血量100~450 ml,平均(256.0±126.5)ml;手术时间180~255 min,平均(215.0±29.4)min;术后住院时间5~12 d,平均(7.2±2.8)d;术后出现胆漏1例,经腹腔引流后痊愈;无围手术期死亡.患者术后第1 d,ALT、AST及TBIL水平有所升高,ALB水平下降,差异有统计学意义(P<0.01);但术后第4 d,所有肝功能监测主要指标已恢复到术前水平,差异无统计学意义(P>0.05).结论 腹腔镜下经肝门板半肝血流阻断法在半肝切除中安全可行.  相似文献   

5.
目的 比较腹腔镜下规则性肝切除与肝肿瘤剥除术治疗肝血管瘤的临床效果.方法 回顾性分析60例肝血管瘤患者的临床资料,其中31例在腹腔镜下行规则性肝切除术为A组,29例腹腔镜下行肝肿瘤剥除术为B组.比较两组手术时间、术中出血量、住院时间、术后并发症及复发率.结果 A组手术时间、术中出血量、住院时间分别为(153.96±37.13)min、(440.08±110.03)ml、(9.03±2.01)d,B组分别为(92.06±27.44)min、(327.21±130.51)ml、(7.17±3.14)d,B组手术时间、术中出血量明显少于A组(P<0.05).两组术后多数出现谷丙转氨酶(ALT)、谷草转氨酶(AST)一过性升高,同时A组出现1例胆漏,均未见切口感染、脂肪液化及死亡等情况发生,术后并发症比较无统计学意义(P>0.05).两组术后随访(13.97±3.09)个月,A、B组复发率分别为6.5%、3.4%,两组比较无统计学意义(P>0.05).结论 治疗肝血管瘤倾向于选择腹腔镜下肝肿瘤剥除术,具有创伤小、恢复快、预后好的优点,但具体选择何种术式仍需根据肿瘤实际情况而定.  相似文献   

6.
目的 总结腹腔镜一期切除治疗直肠癌合并肝转移患者的临床效果.方法 23例直肠癌合并同时性肝转移患者在行腹腔镜直肠癌切除的同时,行肝转移瘤切除,并与同期18例开腹一期切除直肠癌及肝转移瘤患者进行对比研究.全部患者术后均定期全身化疗.结果 所有患者均顺利行直肠癌切除和肝转移瘤切除,腹腔镜组无中转开腹,两组患者均无手术死亡.腹腔镜组和开腹手术组的手术时间分别为(350±45)min和(342±38)min(P>0.05),术中出血量分别为(275±96)ml和(590±85)ml(P<0.01),住院时间分别为(12±1.5)d和(16±2.5)d(P<0.05).腹腔镜组有1例患者手术中输血200 ml,而开腹手术组平均术中输血(500±100)ml(P<0.01).腹腔镜组患者的1、3、5生存率分别为82.6%、43.5%和8.6%,开腹手术组分别为77.8%、38.9%和0,差异无统计学意义(P>0.05).结论 腹腔镜一期切除直肠癌合并同时性肝转移癌安全可行,具有创伤小、恢复快的优点,患者的生存期与开腹一期切除相当.  相似文献   

7.
目的:探讨腹腔镜手术治疗结直肠癌的可行性及近期疗效.方法:2006年4月至2008年6月本院腹部外科收治的结直肠癌患者,以TNM分期为依据,随机分为腹腔镜组59例及常规开腹组70例,对比评估两组的肿瘤切除范围、淋巴结清扫数、术中出血量、手术时间、围手术期输血、术后肠道功能恢复时间、手术对患者机体血常规和生化指标的影响、住院天数、手术费用、术后并发症、复发及转移等.结果:腹腔镜组达到与开腹组同样的肿瘤切除范围和淋巴结清扫(15.28枚vs 14.00枚,P>0.05).腹腔镜组术中出血量少于开腹组(260.68mL vs 304.43mL,P>0.05)、术后肠道功能恢复时间明显早于开腹组(3.20d vs4.30dP<0.05),术后住院天数短于开腹组(9.61d vs 13.06d,P<0.05).手术时间腹腔镜组前期较开腹组长(196.97min vs 156.86min P<0.05),但后期两组无差异(143.85min Vs155.00min P>0.05).手术费用腹腔镜组高于开腹组(51 897.93元vs 48 010.62元人民币,P<0.05).腹腔镜手术对患者血浆白蛋白ALB(35.561g/L vs 33.663g/L,P<0.05)、PALB(15.44g/L vs 13.61g/L,P<0.05)、Tp(65.685g/L Vs 63.863g/L,P<0.05)的影响均较开腹手术者轻.两组随访期间各有并发症5例,并发症率7%~8%,术后转移1例.两组切口均无肿瘤种植、无局部复发及近期死亡病例.结论:腹腔镜结直肠癌手术符合肿瘤根治原则,可达到与开腹手术同样的根治性治疗效果,近期疗效令人满意,并具有切口小、创伤轻、术后恢复快、并发症少、住院时间短、术后生存质量高等优点.腹腔镜结直肠癌手术将有广泛推广应用的价值.  相似文献   

8.
TissueLink技术在肝脏手术中增强止血的作用   总被引:1,自引:0,他引:1  
目的:采用TissueLink技术进行肝肿瘤切除术,通过提高对肝窦和肝内小血管的凝血和止血功能来提高肝手术的精确性和安全性.方法:采用TissueLink技术进行肝肿瘤切除术40例与传统钳折法进行肝切除术40例对比,观察肝门阻断情况、术中出血量、输血情况、手术时间、住院时间等,对手术的精确性、安全性进行评价.结果:采用TissueLink刀进行肝癌切除组术中仅6例短时间阻断肝门血流,其阻断时间为(8.25±1.78)min,平均失血量(160±80.22)ml,输血8例;而传统钳折法肝癌切除组35例阻断肝门血流,阻断时间为(15.18±3.46)min,平均失血量(500±96,23)ml,输血18例,两组各项对比差异显著(均P<0.05).TissueLink刀组手术时间要较对照组长,分别为(65±37.77)min和(35±25.33)min,两组对比差异显著,P<0.05.TissueLink刀组住院日19±3.74,对照组20±3.25,两组对比无显著差异,P>0.05.结论:用TissueLink技术进行肝肿瘤切除可以在不阻断肝门或者减少阻断时间的情况下减少术中失血及术中输血,从而减少肝脏功能的损害,提高于术的精确性和安全性.  相似文献   

9.
目的:探讨腹腔镜肝海绵状血管瘤(肝血管瘤)切除的可行性及方法.方法: 回顾性分析我院采用超声刀为主要切肝器械,并结合pringle法阻断第一肝门,完成腹腔镜肝血管瘤切除7例.包括局部切除4例,左外叶切除3例.结果: 全部顺利完成手术,无中转开腹.手术时间75-225min,(156±47.9)min,术中出血200-1200ml,(460.0± 302.5)ml,术后住院时间3-10d,(6.6±3.0)d,除一例出现广泛皮下气肿外,其余病例未发生严重并发症.术后病理均证实为肝海绵状血管瘤. 结论: 腹腔镜下肝海绵状血管瘤切除对于经选择的病例是安全可行的.  相似文献   

10.
目的 探讨完全腹腔镜解剖性右半肝切除术在治疗肝肿瘤中的安全性和临床效果.方法 回顾性分析2014年1月至2015年12月我院完全腹腔镜解剖性右半肝切除治疗的肝肿瘤患者的临床资料.观察患者的手术时间、术中失血量、术后并发症等.采取右半肝人肝血流完全阻断,断肝方式为超声刀联合双极电凝.其中2例原发性肝癌,1例肝血管瘤.结果 3例患者均成功施行手术.手术时间分别为385 min、320 min和265m in,出血量分别为500 mL、400 mL和230 mL,其中1例输浓缩红细胞1.0u.3例患者术后均无胆漏发生.1例患者术后出现右侧胸腔积液,1例患者术后出现双侧胸腔积液,均行胸腔穿刺置管引流.术后住院时间分别为11d、11d、12 d.3例患者术后恢复均顺利.2例原发性肝癌患者术后随访分别为26个月和17个月,均未发现局部复发和远处转移.结论 完全腹腔镜解剖性右半肝切除治疗合适的肝肿瘤安全、有效.  相似文献   

11.
BACKGROUND: The safety and short-term benefits of laparoscopic colectomy for cancer remain debatable. The multicentre COLOR (COlon cancer Laparoscopic or Open Resection) trial was done to assess the safety and benefit of laparoscopic resection compared with open resection for curative treatment of patients with cancer of the right or left colon. METHODS: 627 patients were randomly assigned to laparoscopic surgery and 621 patients to open surgery. The primary endpoint was cancer-free survival 3 years after surgery. Secondary outcomes were short-term morbidity and mortality, number of positive resection margins, local recurrence, port-site or wound-site recurrence, metastasis, overall survival, and blood loss during surgery. Analysis was by intention to treat. Here, clinical characteristics, operative findings, and postoperative outcome are reported. FINDINGS: Patients assigned laparoscopic resection had less blood loss compared with those assigned open resection (median 100 mL [range 0-2700] vs 175 mL [0-2000], p<0.0001), although laparoscopic surgery lasted 30 min longer than did open surgery (p<0.0001). Conversion to open surgery was needed for 91 (17%) patients undergoing the laparoscopic procedure. Radicality of resection as assessed by number of removed lymph nodes and length of resected oral and aboral bowel did not differ between groups. Laparoscopic colectomy was associated with earlier recovery of bowel function (p<0.0001), need for fewer analgesics, and with a shorter hospital stay (p<0.0001) compared with open colectomy. Morbidity and mortality 28 days after colectomy did not differ between groups. INTERPRETATION: Laparoscopic surgery can be used for safe and radical resection of cancer in the right, left, and sigmoid colon.  相似文献   

12.
Background:Laparoscopic hepatectomy for hepatocellular carcinoma (HCC) located in segment Ⅵ,Ⅶ,or Ⅷ of the liver is usually difficult because of poor operative exposure,due to the unique anatomical structure.In this study,we evaluated the practice of laparoscopic hepatectomy with the left jackknife position for patients with HCC located in segment Ⅵ,Ⅶ,or Ⅷ.Methods:A total of 10 patients were enrolled to undergo laparoscopic hepatectomy with the left jackknife position.Tumors located in segment Ⅵ,Ⅶ,or Ⅷ were assessed by preoperative dynamic computed tomography or magnetic resonance imaging.Operation time,intraoperative blood loss,postoperative fasting time,postoperative drainage time,major postoperative complications,and duration of postoperative hospital stay were recorded.Results:All surgeries were successfully completed.None of the patients required conversion to open surgery during the procedure,and no serious postoperative complications were observed.The median tumor size was 31 mm (range 23-41 mm) in diameter,the mean operation time was 166 ± 38 min,the mean intraoperative blood loss was 220 ± 135 mL,and the median postoperative hospital stay was 4 days (range 2-7 days).Conclusions:For HCC located in segment Ⅵ,Ⅶ,or Ⅷ,laparoscopic hepatectomy with this novel position—the left jackknife position—is safe and effective during tumor resection by exposing a sufficient operating field.  相似文献   

13.

Objective

The aim of our study was to retrospectively analyze 15 patients’ clinical materials with laparoscopic resection of liver neoplasms.

Methods

From December 2007, a total of 15 patients with liver neoplasms were performed with laparoscopic hepatectomy, and their clinical materials, perioperative dates, postoperative complications, postoperative recovery and short-term curative effects were analyzed and summarized respectively.

Results

Laparoscopic hepatectomy (LH) were performed in 15 patients, including 1 case underwent laparoscopic hepatic left lobectomy, 1 case of left lateral hepatectomy, 13 cases of partial liver resection. Fourteen cases of total laparoscopic liver resections for liver neoplasms, 1 case of hand-assisted laparoscopic liver resection of the tumor, there was no conversion to open approach. Of the 15 patients with liver neoplasms, 13 cases of hepatic neoplasms with the maximum diameter was 8 cm × 8 cm × 9 cm, 9 cases of the borderline micro hepatocellular carcinoma (MHCC) with the diameter not more than 2 cm, 3 cases of hepatic benign tumor. The mean operation time was (120 ± 30) min, and the intraoperative average hemorrhage was 100 mL, beginning to eat and get out of bed following 1–2 days of operation. The average postoperative hospitalization was 8 days, WBC, ALT, AST, albumin, bilirubin returned to normal after one week of operation. There were no postoperative complications such as hemorrhage, bile leakage or air embolism etc. Twelve patients with HCC were confirmed by postoperative pathology, 1 case of liver smooth muscle lipoma, 2 case of hepatic hemangioma. By one year of followed-up in 12 cases of HCC, the longest survival was 38 months, and no recurrence or death, 1 year survival rate was 100%.

Conclusion

Among the choice of cases, the advantages of LH for liver neoplasms compared with open surgery were less trauma, faster recovery and less blood loss. it is safe and effective for choosing a reasonable surgical indication, especially for peripheral micro hepatocellular carcinoma.  相似文献   

14.
 目的 探讨伴呼吸功能障碍的结直肠癌患者接受腹腔镜治疗的可行性。方法 总结2007年8月至2009年11月收治的伴呼吸功能障碍的结直肠癌患者64例。遵循肿瘤根治原则,36例接受腹腔镜手术,28例行常规开腹手术。结果 腹腔镜组术后吸氧时间平均3.5 d,开腹组平均4.6 d(P<0.05);自主咳痰能力优于开腹组(P<0.05);腹腔镜组术后气管插管拔除时间平均21.2 min、开腹组平均23.9 min,差异无统计学意义(P>0.05);两组患者术后血氧饱和度波动范围腹腔镜组略优于开腹组,但差异无统计学意义(P>0.05);开腹组肺部感染1例,两组患者均无肺不张、呼吸衰竭及泌尿系感染病例。结论 伴呼吸功能障碍的结直肠癌患者适合应用腹腔镜手术治疗。  相似文献   

15.
《癌症》2016,(5):25-31
Background: Laparoscopic hepatectomy is increasingly being used to treat hepatocellular carcinoma (HCC). How?ever, few studies have examined the treatment of recurrent HCC in patients who received a prior hepatectomy. The present prospective study compared the clinical efcacy of laparoscopic surgery with conventional open surgery in HCC patients with postoperative tumor recurrence. Methods: We conducted a prospective study of 64 patients, all of whom had undergone open surgery once before, who were diagnosed with recurrent HCC between June 2014 and November 2014. The laparoscopic group (n = 31)underwent laparoscopic hepatectomy, and the control group (n tion time, intraoperative blood loss, surgical margins, postoperative pain scores, postoperative time until the patient= 33) underwent conventional open surgery. Opera?could walk, anal exsufation time, length of hospital stay, and inpatient costs were compared between the two groups. The patients were followed up for 1 year after surgery, and relapse?free survival was compared between the two groups. Results: All surgeries were successfully completed. No conversion to open surgery occurred in the laparoscopic group, and no serious postoperative complications occurred in either group. No significant difference in inpatient costs was found between the laparoscopic group and the control group (P = 0.079), but significant differencesbetween the two groups were observed for operation time (116.7 ± 37.5 vs. 148.2 ± 46.7 min, P = 0.031), intraopera?tive blood loss (117.5 ± 35.5 vs. 265.9 ± 70.3 mL, P = 0.012), postoperative time until the patient could walk (1.6 ± 0.6vs. 2.2 ± 0.8 days, P < 0.05), anal exsufation time (2.1 ± 0.3 vs. 2.8 ± 0.7 days, P = 0.041), visual analogue scale pain score (P < 0.05), postoperative hepatic function (P < 0.05), and length of hospital stay (4.5 ± 1.3 vs. 6.0 ± 1.2 days,P= 0.014). During the 1?year postoperative follow?up period, 6 patients in each group had recurrent HCC on the side of the initial operation, but no significant difference between groups was observed in the recurrence rate or relapse?free survival. In the laparoscopic group, operation time, postoperative time until the patient could walk, anal exsufation time, and inpatient costs were not different (P > 0.05) between the patients with contralateral HCC recur?rence (n = 18) and those with ipsilateral HCC recurrence (n = 13). However, intraoperative blood loss was signifi?cantly less (97.7 ± 14.0 vs. 186.3 ± 125.6 mL, P = 0.012) and the hospital stay was significantly shorter (4.2 ± 0.7 vs. 6.1 ± 1.7 days, P = 0.021) for the patients with contralateral recurrence than for those with ipsilateral recurrence. Conclusions: For the patients who previously underwent conventional open surgical resection of HCC, complete laparoscopic resection was safe and effective for recurrent HCC and resulted in a shorter operation time, less intraop?erative blood loss, and a faster postoperative recovery than conventional open surgery. Laparoscopic resection was especially advantageous for the patients with contralateral HCC recurrence.  相似文献   

16.
目的:研究腹腔镜肝癌根治术治疗肝癌的临床疗效及对神经生长因子(nerve growth factor,NGF)、基质金属蛋白酶-13(matrix metalloproteinase-13,MMP-13)水平的影响。方法:选取2012年1月至2016年12月我院收治的原发性肝癌患者65例,分别采用开腹肝癌切除术(对照组)和腹腔镜肝癌根治术(观察组),分析两组患者治疗后的临床效果。结果:观察组患者手术时间、排气时间、拔管时间、绝对卧床时间、住院时间均短于对照组;术后3 d时,观察组患者MMP-13、ICAM-1、NGF、PⅢP、PCT水平低于对照组;术后1个月,观察组患者肝功能指标水平低于对照组,差异有统计学意义(P<0.05)。随访1年后,观察组患者复发率和转移率分别为15.15%、3.03%;对照组分别为28.13%、12.50%;观察组患者复发率和转移率低于对照组,但组间比较无统计学差异(P>0.05)。结论:腹腔镜肝癌根治术较开腹肝癌切除术治疗肝癌更有利于促进肝功能的恢复,可降低MMP-13及NGF水平,且恢复快,住院时间短,但复发率和转移率比较,无明显差异。  相似文献   

17.
IntroductionLaparoscopic liver resection(LLR) for intrahepatic cholangiocarcinoma is debatable due to technical challenges associated with major hepatectomy and lymph node dissection. This study aims to analyze the long-term outcomes with propensity score matching.MethodsPatients who underwent liver resection for intrahepatic cholangiocarcinoma from August 2004 to October 2015 were enrolled. Those who had combined hepatocellular-cholangiocarcinoma and palliative surgery were excluded. Medical records were reviewed for postoperative outcome, recurrence, and survival. The 3-year disease-free survival(DFS) and 3-year overall survival(OS) were set as the primary endpoint, and 3-year disease-specific survival, 1-year OS, 1-year DFS, operative outcome, and postoperative complications were secondary endpoints.ResultsA total of 91 patients were enrolled with 61 in the open group and 30 in the laparoscopic group. Propensity score matching included 24 patients in both groups. In total, the 3-year OS was 81.2% in the open group and 76.7% in the laparoscopic group(p = 0.621). For 3-year DFS, open was 42.5% and laparoscopic was 65.6%(p = 0.122). Mean operation time for the open group was 343.2 ± 106.0 min and laparoscopic group was 375.2 ± 204.0 min(p = 0.426). Hospital stay was significantly shorter in the laparoscopic group(9.8 ± 5.1 days) than the open group(18.3 ± 14.7, p=<0.001). There was no difference in complication rate and 30-day readmission rate. Tumor size, nodularity, and presence of perineural invasion showed an independent association with the 3-year DFS in multivariate analysis.ConclusionLaparoscopic liver resection for intrahepatic cholangiocarcinoma is technically feasible and safe, providing short-term benefits without increasing complications or affecting long-term survival.  相似文献   

18.
AIMS: Surgical radiofrequency ablation (RFA) of hepatic malignancies is associated with superior oncological outcome as compared to percutaneous RFA. The aim of this prospective non-randomized cohort study was to compare morbidity and mortality of laparoscopic (LRFA) vs. open (ORFA) radiofrequency ablation of liver cancer. METHODS: Between October 1999 and November 2006, RFA was performed in 154 consecutive patients (percutaneous 12, LRFA 93, ORFA 49) for a total of 291 hepatic tumours (HCC 81, colorectal metastases 157, other 53). Seventy-four patients simultaneously underwent additional surgery. Laparoscopic RFA was performed in 45/54 patients with HCC, and in 44/54 patients with cirrhosis. Laparotomy was performed in 14/22 patients who underwent simultaneous colorectal resection, and in 12/22 patients with hepatic resection. RESULTS: Postoperative complications occurred in 25 patients with subsequent mortality in 2. As compared with LRFA, ORFA was associated with significantly (p<0.01) higher intra-operative blood loss (median 20 (range 0-1700) vs. 10 (0-900) ml), longer duration of surgery (180 (25-440) vs. 75 (30-390) min), more postoperative complications (17 vs. 8), and longer postoperative hospital stay (8 (1-127) vs. 4 (1-51) d). According to the therapy-oriented severity grading system (TOSGS) classification, postoperative complications in the ORFA-group were more severe than those in the LRFA-group (p<0.01). These findings were consistent in patients without simultaneous colorectal and/or hepatic resection and in patients with liver tumours measuring 3cm or less. In univariate analysis the following factors were significantly (p<0.01) related to the presence of postoperative complications: simultaneous colorectal resection, laparotomy, duration of surgery, tumour location in right liver, liver segment 7 (p=0.01), absence of cirrhosis (p=0.02), liver segment 8 (p=0.03), and metastatic liver cancer (p=0.04). CONCLUSION: LRFA for hepatic malignancies seems preferable above ORFA, provided good patient selection, surgical expertise, and long-term oncological control.  相似文献   

19.
目的探讨分析腹腔镜下结直肠癌根治的安全性和可行性,对比其与开腹手术的近远期疗效。方法回顾性分析我院2006年1月至2011年12月间结肠及中上段直肠癌根治术患者的临床资料,其中开腹手术120例,腹腔镜下手术76例。分析比较两组患者的临床病理资料、围手术期情况及近远期生存情况。结果两组患者年龄、性别比较无统计学差异。腹腔镜组平均手术时间大于开腹组,分别为(226.28±61.09)min和(193.50±53.79)min;术中失血量腹腔镜组小于开腹组,分别为(84.00±28.41)ml和(187.60±37.27)ml;术后住院时间腹腔镜组小于开腹组,分别为(7.55±2.04)d和(8.40±3.39)d。两组患者肠管近端及远端切缘长度、清扫淋巴结数目以及术后感染性和非感染性并发症发生率比较,差异无统计学意义。开腹组与腹腔镜组结直肠癌患者术后3、5年生存率分别为76.8%、65.7%和76.6%、71.2%(P>0.05);Duke’s A、B、C各期两组患者生存率比较无统计学差异。结论腹腔镜结直肠癌根治手术安全可行,具有出血少、术后恢复快等优点,肿瘤安全性、并发症发生率及术后近远期疗效不亚于开腹手术。  相似文献   

20.
Background: Surgery offers the only potential for cure and long-term survival of recurrence of rectal cancer.Few studies about laparoscopic recurrent lesion resection have been reported. This study was designed to evaluatethe safety and feasibility of laparoscopic abdomino-perineal resection for anastomotic recurrence of rectal cancer.Materials and Methods: Data for 42 patients with recurrence of rectal cancer were collected retrospectively. Of the42 patients, 22 underwent laparoscopic surgery (LR group) and 20 received open surgery (OR group). Outcomesbetween the two groups were compared. Results: Operation time in LR group was shorter compared with theOR group (164.6±27.7min vs 203.0±45.3min); intra-operative blood loss was 119.7±44.4ml and 185.0±94.0ml inLR group and OR group, respectively (p<0.001); time to first flatus in LR group was shorter than in OR group,and the difference was statistically significant (2.6±0.8 days vs 3.1±0.8 days, p=0.013); hospital stay in the LRand OR groups was 8.6±1.3 days and 9.8±2.2 days; 3-year survival rates in the LR and OR groups were 44.4%and 42.8% (p=0.915) and the 3-year disease-free survival rates were 36.4% and 30.0%, respectively (p=0.737).Conclusions: Laparoscopic abdomino-perineal resection is safe and feasible for anastomotic recurrence of rectalcancer.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号